Drug
Drugs, Investigational clinical trials
- studies test it
- 13
- open now
- 3
- in phase 3
- 1
- first study started
- 2002
Keep track of what changes. Save the Drugs, Investigational studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 6
- Phase 3
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 4
Novartis (2) · Pfizer (2) · EyeD Pharma (2) · Hasanuddin University (1) · University Children's Hospital Basel (1) · Chittagong Medical College (1) · Chinese PLA General Hospital (1) · Sun Pharmaceutical Industries Limited (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Drugs, Investigational is read from its arms, and is right about nine times in ten.
Testing it · 13
- An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the FaceRecruitingPhase 1Sun Pharmaceutical Industries LimitedNCT07729579Written as Investigational drug
- Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract SurgeryRecruitingPhase 1/2EyeD PharmaNCT07036510Written as TimoD implant
- The Impact of Intrapleural Block on Postoperative Pain Caused by Drainage Tubes After Thoracoscopic SurgeryNot yet recruitingNot applicableChinese PLA General HospitalNCT07294755Written as Investigational drug 20 mL of 0.5% ropivacaine
- I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisActive, not recruitingNot applicableHasanuddin UniversityNCT07186478Written as Investigational Drug
- Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle GlaucomaTerminatedPhase 1EyeD PharmaNCT06321562Written as TimoD implant
- Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting ConditionsCompletedEarly Phase 1University Children's Hospital BaselNCT05477810Written as Treatment A (investigational drug) followed by Treatment B (reference drug)
- Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset SeizuresCompletedPhase 2NovartisNCT01147003Written as Investigational new drug, company code: BGG492
- The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle GlaucomaCompletedPhase 2Chittagong Medical CollegeNCT04205201Written as Drugs, Investigational
- Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy SurgeryCompletedPhase 2NovartisNCT00887861Written as Investigational new drug, company code: BGG492
- A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal CancerTerminatedPhase 2Celgene CorporationNCT00040391Written as Investigational drug
- Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)CompletedPhase 2PfizerNCT00034957Written as Investigational drug
- The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's DiseaseTerminatedPhase 3Merck Sharp & Dohme LLCNCT00006187Written as Investigational drug
- Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple MyelomaCompletedPhase 1PfizerNCT00036140Written as Investigational drug
Codes
What other systems call Drugs, Investigational · ClinicalTrials.gg INT008471
- MeSH (NLM) D015507Drugs, InvestigationalOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D015507 | Drugs, Investigational | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.